Menu

Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says

Bloomberg Markets·Sanne Wass·about 13 hours ago
#MiDFzKOG
#bloomberg#business#pharma#delaying#plans
Reading 0:00
15s threshold

Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.

Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.